What is the role of tazarotene, etoposide, or imiquimod in the treatment of early cutaneous T-cell lymphoma (CTCL)?

Updated: Aug 15, 2018
  • Author: Lauren C Pinter-Brown, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Tazarotene, long-term and low-dose oral etoposide, and imiquimod may be of value in the treatment of early cutaneous T-cell lymphoma. [110, 111] One small pilot study showed tazarotene 0.1% gel to be a well-tolerated and effective adjuvant topical therapy for the treatment of refractory mycosis fungoides. [112]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!